BACKGROUND: Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are two prominent signaling lysophospholipids (LPs) exerting their functions through a group of G protein-coupled receptors (GPCRs). This review covers current knowledge of the LP signaling in the function and pathology of the reproductive system. METHODS: PubMed was searched up to May 2008 for papers on lysophospholipids/LPA/S1P/LPC/SPC in combination with each part of the reproductive system, such as testis/ovary/uterus. RESULTS: LPA and SIP are found in significant amounts in serum and other biological fluids. To date, 10 LP receptors have been identified, including LPA 1 -5 and S1P 1 -5 . In vitro and in vivo studies from the past three decades have demonstrated or suggested the physiological functions of LP signaling in reproduction, such as spermatogenesis, male sexual function, ovarian function, fertilization, early embryo development, embryo spacing, implantation, decidualization, pregnancy maintenance and parturition, as well as pathological roles in ovary, cervix, mammary gland and prostate cancers. CONCLUSIONS: Receptor knock-out and other studies indicate tissue-specific and receptor-specific functions of LP signaling in reproduction. More comprehensive studies are required to define mechanisms of LP signaling and explore the potential use as a therapeutic target.
Introduction
Lysophospholipids (LPs) were originally recognized as quantitatively minor lipid species produced during the biosynthesis of membrane phospholipids (Pieringer et al., 1967) . The signaling properties of LPs were initially noticed in the 1960s (Vogt, 1963) . Later, more studies established LPs as signaling molecules (Tokumura et al., 1978 (Tokumura et al., , 1980 van Corven et al., 1989; Durieux et al., 1993; Hill et al., 1994a) . LPs demonstrated to be involved in signaling include lysophosphatidic acid (LPA), sphingosine-1-phosphate (S1P), lysophosphatidylcholine (LPC) and sphingosylphosphorylcholine (SPC). Early studies revealed the effects of LPA on blood pressure, uterine smooth muscle contraction and platelet aggregation (Tokumura et al., 1978 (Tokumura et al., , 1980 Gerrard et al., 1979; Schumacher et al., 1979) . Subsequently, numerous studies identified a range of physiological processes in which LPs were involved, e.g. cell proliferation (van Corven et al., 1989; Zhang et al., 1991; Olivera and Spiegel, 1993; Goodemote et al., 1995; Yoshida et al., 1996) , cell survival (Cuvillier et al., 1996; Van Brocklyn et al., 1998; Goetzl et al., 1999; Weiner and Chun, 1999) , cell differentiation (Piazza et al., 1995; Sato et al., 1998) , cell morphological changes (Ridley and Hall, 1992; Jalink et al., 1993 Jalink et al., , 1994 Bornfeldt et al., 1995; Postma et al., 1996; Sato et al., 1997; Fukushima et al., 1998) , regulation of gap junctions (Hill et al., 1994a) , stimulation of the serum response element (Hill et al., 1994b) , induction of inward ion currents (Durieux et al., 1993) , etc. These broad biological effects have attracted increasing attention to LP signaling research in recent years. A significant portion of the recent discoveries are related to reproduction. This review will briefly introduce receptor-mediated LP signaling and comprehensively update the physiological and pathological functions of LP signaling in the reproductive system.
Materials and Methods
PubMed was searched up to May 2008 for papers on lysophospholipids/LPA/S1P/LPC/SPC in combination with each part of the reproductive system, such as testis/ovary/uterus.
Signaling LPs and LP signaling
Extracellular signaling LPs have simple chemical structures: a 3-carbon glycerol or a sphingoid backbone with a single acyl chain of varied length and saturation (Ishii et al., 2004) . LPA and S1P are the most studied extracellular signaling LPs. Some LPs also have intracellular functions that are not covered here (Spiegel et al., 1994 Spiegel and Milstien, 2003; Pebay et al., 2007; Valentine et al., 2007) .
LPA has been detected in significant amounts in biological fluids such as serum (up to micromolar concentration) and plasma (Tokumura et al., 1986; Baker et al., 2000; Aoki et al., 2002; Sano et al., 2002) , saliva (Sugiura et al., 2002) , blister fluid (Mazereeuw-Hautier et al., 2005) , tear (Liliom et al., 1998) , hen egg white (Nakane et al., 2001) , follicular fluid , seminal plasma and ascites (Xu et al., 1995b (Xu et al., , 1998 Tokumura et al., 2007) . Evidence has shown that many cell types such as activated platelets (Mauco et al., 1978; Gerrard and Robinson, 1989; Eichholtz et al., 1993; Fourcade et al., 1995) , erythrocytes (Fourcade et al., 1995) , postmitotic neurons , ovarian and cervical cancer cells (Shen et al., 1998; Eder et al., 2000; Luquain et al., 2003) , adipocytes (Gesta et al., 2002) and mast cells (Mori et al., 2007) are able to produce LPA.
The main pathways for LPA production may differ in various cell types and the metabolism of LPA in most cell types is still unclear (Aoki, 2004) . Studies on the production of extracellular LPA in the serum have suggested two main pathways involving phospholipase D (PLD), phospholipase A1 (PLA1), phospholipase A2 (PLA2) and autotaxin/lysophospholipase D (ATX/lysoPLD) ( Fig. 1) . One main pathway is the cleavage of phospholipids (PLs) by PLD to form phosphatidic acids (PAs). LPA is generated from hydrolysis of PAs by PLA1 and PLA2, this process can be reversed by LPA acyltransferases (Leung, 2001) . The other main pathway is the cleavage of LPs such as LPC, lysophosphatidylethanolamine and lysophosphatidylserine, by ATX/lysoPLD to free LPA. PLA1 and PLA2 are involved in the production of LPs from membrane PLs in this pathway. LPA is dephosphorylated to monoacylglycerol by a family of three membrane-bound lipid phosphate phosphatases (LPP1, LPP2 and LPP3). Extracellular LPA is normally bound to molecules, such as albumin, fatty acid binding proteins, gelsolin and lipoproteins, for transportation and stability (Gaits et al., 1997; Pages et al., 2001; Mills and Moolenaar, 2003; Aoki, 2004) . S1P also is found in significant levels in serum and plasma (Yatomi et al., 2001) . Major sources are platelets and erythrocytes English et al., 2000; Hanel et al., 2007; Ito et al., 2007; Pappu et al., 2007) . Lung endothelial cells and mast cells (Mitra et al., 2006) can also produce this molecule. S1P is the product of sphingosine phosphorylation by sphingosine kinases (SphK1 and SphK2). Sphingosine is produced from ceramide, a pro-apoptotic factor. Specific dephosphorylation of S1P by S1P phosphohydrolases or non-specific dephosphorylation of S1P by LPPs can reverse this process. S1P is metabolized by S1P lyase to form phosphoethanolamine and hexadecenal (Brindley et al., 2002; Le Stunff et al., 2004) . As with LPA, extracellular S1P is also bound to molecules, such as serum albumin and lipoproteins (Okajima 2002; Kobayashi et al., 2006) .
Previous debates about the mechanisms of extracellular LP signaling have been silenced by the identification of molecularly cloned receptors (Chun, 1999; Chun et al., 2000; Fukushima et al., 2001; Ishii et al., 2004) . While the majority of rigorous data supported the existence of specific receptors for extracellular LPA and S1P, other data, such as the reported lack of stereo-specific effects, the detergentlike chemical structures and the use of LPs at high concentrations were consistent with actions via non-receptor mechanisms such as membrane perturbation or disruption. The cloning of the first LPA receptor in 1996 (Hecht et al., 1996) and the following identification of nine more LP receptors, as well as the establishement of receptor-specific functions, have clearly defined a receptor-mediated mechanism for the effects of extracellular LPs (Moolenaar, 2000; Spiegel and Milstien, 2003; Anliker and Chun, 2004; Ishii et al., 2004; Birgbauer and Chun, 2006; Gardell et al., 2006; Meyer zu Heringdorf and Jakobs, 2007; Watterson et al., 2007) .
The 10 so far identified LP receptors include LPA 1 -5 and S1P 1 -5 (Table I) . Suggested additional possible LP receptor candidates include: GPR87 and P2Y5 for LPA (Tabata et al., 2007; Pasternack et al., 2008) ; GPR3 and GPR12 for S1P and SPC (Uhlenbrock et al., 2002 (Uhlenbrock et al., , 2003 Hinckley et al., 2005) ; G2A for LPC; OGR1 and GPR4 for SPC, etc (Xu 2002; Bektas et al., 2003; Ishii et al., 2004; Murakami et al., 2004; Seuwen et al., 2006) . LPA 1 -5 and S1P 1 -5 are transmembrane G protein-coupled receptors (GPCRs). They can differentially couple with G 12/13 , G q , G i/o or G s to activate the downstream signaling cascades and eventually lead to LP-induced cellular functions, such as cell proliferation, cell survival, cell differentiation and cell morphological changes (Table I) (Fig. 1) Ishii et al., 2004; Gardell et al., 2006; Hannun and Obeid, 2008) .
The LP receptors have overlapping expression patterns in specific tissues and each receptor has its unique expression profile. Based on data from northern analyses, the expression of LPA 1 , S1P 1 , S1P 2 and S1P 3 is ubiquitous although the expression levels in different tissues vary, whereas the expression of other receptors is more confined: LPA 2 is highly expressed in testis and kidney; LPA 3 in testis, kidney and lung; LPA 4 in heart and skin; LPA 5 in small intestine and stomach, with lower levels in skin, spleen and thymus; S1P 4 in lung, thymus and spleen; S1P 5 in brain and skin (Contos et al., 2000b; Ishii et al., 2001; Lee et al., 2006a Lee et al., , 2007 . The expression of LP receptors in the reproductive tissues are summarized in Table II . Moreover, LP receptors may have preferences for different ligands. For example, LPA 3 is not as responsive as LPA 1 and LPA 2 to LPA species with saturated acyl chains but has a relatively high affinity for 2-acyl-LPA containing unsaturated fatty acids (Bandoh et al., 1999; Fischer et al., 2001; Sonoda et al., 2002) . The differential coupling to G proteins, the differential receptor expression patterns and ligand specificity may contribute to LP receptor-specific functions.
The specific functions of LP receptors have been determined through molecular, biochemical, physiological, pharmacological and genetic approaches. Receptor-mediated LP signaling has broad implications in the nervous system. For example, LPA 1 is involved in neuropathic pain, suckling behavior, psychiatric disease such as schizophrenia, Schwann cell survival and morphological change, and astrocyte proliferation (Weiner and Chun, 1999; Contos et al., 2000a; Renback et al., 2000; Weiner et al., 2001; Harrison et al., 2003; Inoue et al., 2004 Inoue et al., , 2006 Shano et al., 2008) , while LPA 1 and LPA 2 mediate brain formation (Kingsbury et al., 2003; Estivill-Torrus et al., 2008) . S1P 2 plays a role in seizure and hearing (MacLennan et al., 2001 (MacLennan et al., , 2006 Kono et al., 2007a) , while S1P 5 is involved in development of oligodendroglial cells (Jaillard et al., 2005) and S1P receptor(s) are implicated in multiple sclerosis (Webb et al., 2004) . LPA 1 and S1P 1 -3 have crucial roles in cardiovascular system processes, such as angiogenesis, atherosclerosis and cardiac myocyte survival (Contos et al., 2000a; Liu et al., 2000; Siess, 2002; Allende et al., 2003; Kono et al., 2004; Siess and Tigyi, 2004; Maguire and Davenport, 2005; . LPA 1 -3 and S1P 1 -3 have been implicated in processes of the respiratory system: proinflammatory effects, acute respiratory distress syndrome and chronic inflammatory airway diseases (Ammit et al., 2001; Jolly et al., 2002; Konishi et al., 2002; Gon et al., 2005; Saatian et al., 2006; Kono et al., 2007b) . LPA 1 -3 , S1P 1 , S1P 3 and S1P 4 can mediate LP functions in the immune system (Zheng et al., 2001; Graler and Goetzl, 2002; Bagga et al., 2004; Goetzl et al., 2004; Matsuyuki et al., 2006; Chan et al., 2007; Czeloth et al., 2007; Pappu et al., 2007; Wang et al., 2007b) . In fact, FTY720, a broad-spectrum S1P receptor agonist, is in phase III studies for treating demyelinating diseases, specifically multiple sclerosis (Budde et al., 2006; Chun and Rosen, 2006; Mullershausen et al., 2007; Zhang and Schluesener, 2007) . LPA 1 has a specific function in craniofacial formation (Contos et al., 2000a) . LPA 3 plays a critical role in embryo implantation and spacing Hama et al., 2007) . In addition, receptor-mediated LP signaling has been implicated in stem cells and wound healing (Pebay et al., 2007; Watterson et al., 2007) , as well as multiple cancers including ovarian, prostate, renal, bladder, breast, liver and other forms (Azuma et al., 2002 (Azuma et al., , 2003 Mills and Moolenaar, 2003; Xu et al., 2003; Lee et al., 2005; Murph and Mills, 2007; Ng et al., 2007; Ubai et al., 2007; van Meeteren and Moolenaar, 2007) . The roles of identified receptor-mediated LP signaling in reproduction are summarized in Table III . (metabolism) ATX/lysoPLD, lysophospholipase D/Autotaxin; LPA, lysophosphatidic acid; LPAAT, LPA acyltransferases; LPPs, lipid phosphate phosphatases; LPs, lysophospholipids; PA, phosphatidic acids; PLD, phospholipase D; PLA1/2, phospholipase A1 and A2; PLs, phospholipids; S1P, sphingosine-1-phosphate; SphK1/2, sphingosine kinases 1 and 2; SPPs, S1P phosphohydrolases; (downstream signaling) AC, adenylyl cyclase; Akt, protein kinase B; Ca 2þ , calcium; cAMP, cyclic AMP; CARMA3, CARD and MAGUK domain-containing protein 3; DAG, diacylglycerol; IP 3 , inositol 1,4,5-trisphosphate; MAPK, mitogenactivated protein kinase; MEK, MAPK kinase; MEKK1, MEK kinase 1; NF-kB, nuclear factor kappaB; PI3K, phosphoinositol 3-kinase; PKCa, protein kinase C alpha; PLC, phospholipase C; ROCK, Rho-associated kinase; uPA, urokinase plasminogen activator. Note: the shown downstream signaling pathways are mediated through the specific G proteins but not all the LP receptors that activate these specific G proteins are necessarily involved in mediating these pathways.
LP signaling in testis
It was speculated for at least three reasons that LPA signaling had potential roles in male reproduction (Budnik and Mukhopadhyay, 2002b) . First, LPA biosynthetic enzymes, including PLA1 and PLA2, and autotaxin/lysoPLD are present in the testis (Higgs and Glomset, 1996; Lee et al., 1996; Ito et al., 2002; Sonoda et al., 2002; Hiramatsu et al., 2003; Aoki, 2004; Xie and Meier, 2004) . Second, LPA 1 , LPA 2 and LPA 3 are highly expressed in the mouse testis (Contos et al., 2000b) , while LPA 4 was detected in the human testis (Noguchi et al., 2003) . Third, the transgenic mice overexpressing LPP1, which degrades LPA, showed severely impaired spermatogenesis (Yue et al., 2004) . In situ hybridization demonstrated that LPA 1 , LPA 2 and LPA 3 are expressed in the male germ cells. Deletion of these receptors in mice led to a testosterone-independent reduction of mating activity and sperm counts, with an increased prevalence of azoospermia in aging animals. The physiological mechanism by which the deletion of these receptors led to reduced mating activity is not readily apparent. Increased germ cell apoptosis was responsible for the consequent reduction of germ cell proliferation and the diminished sperm counts, indicating LPA signaling as a germ cell survival factor in spermatogenesis (Ye et al., 2008) .
Northern analysis indicated S1P 2 and S1P 3 at medium expression levels, S1P 1 barely detectable, and S1P 4 and S1P 5 undetectable in the adult mouse testis . RT-PCR detected S1P 1 , S1P 2 and S1P 5 in mouse spermatozoa (Matsumoto et al., 2005) . S1P 1 and S1P 2 were detected by immunohistochemistry in human Sertoli cells, with occasional and weak staining in the spermatogonia and early meiotic spermatocytes .
As with LPA, S1P seemed to be a survival factor for male germ cells. S1P partially protected mouse testicular germ cells against radiation-induced cell death (Otala et al., 2004) and inhibited human germ cell apoptosis in a culture of human seminiferous tubules. Nuclear factor kappaB (NF-kappaB) and protein kinase B (Akt) phosphorylation were implicated in the effect in humans, but a receptor-independent mechanism was proposed . Furthermore, disruption of S1P lyase, which degrades S1P and regulates the ratio of pro-apoptotic ceramide and anti-apoptotic S1P, led to reduced testis size in Drosophila caused by increased apoptosis (Phan et al., 2007) . In addition, sphingolipid signaling is The listed references were the original ones describing the identification of LP receptors. Please refer to the following references for more complete information of each LP receptor (Moolenaar, 2000; Hla et al., 2001; Mills and Moolenaar, 2003; Anliker and Chun, 2004; Ishii et al., 2004; Birgbauer and Chun, 2006; Chun and Rosen, 2006; Gardell et al., 2006; Lee et al., 2006a; Milstien and Spiegel, 2006; Lee et al., 2007; Meyer zu Heringdorf and Jakobs, 2007; Pebay et al., 2007; Yanagida et al., 2007) . 
Up-regulation in pathological conditions, such as hypertensive disorder and tumorigenesis. Quantitative or semi-quantitative result: þþþ, high level of expression; þþ, medium level of expression; þ, low level of expression; þ/2, extremely low level of expression. Non-quantitative result: p , detectable; x, undetectable. h, LPA 4 is detectable in human testis; p, LPA 3 is detectable in pig uterus. M, mouse tissue; H, human tissue; E3.5, embryonic day 3.5; ND, no data. References: (X. Ye and J. Chun, unpublished data; Im et al., 2000b; Ishii et al., 2001; Noguchi et al., 2003; Kitayama et al., 2004; Liu and Armant, 2004; Hinckley et al., 2005; Johnstone et al., 2005; Nakamoto et al., 2005; di Villa Bianca et al., 2006; Guo et al., 2006; Kotarsky et al., 2006; Skaznik-Wikiel et al., 2006; Kaminska et al., 2007; Li et al., 2007; Wang et al., 2007a; Ye et al., 2008) .
critical for male gametophyte development in Arabidopsis (Teng et al., 2008) .
LP signaling in male sexual function
Reports have suggested that LP signaling may also participate in male sexual function. LPC is a major component of atherogenic oxidized low-density lipoproteins related to hypercholesterolemia, which can cause erectile dysfunction (Jung et al., 2007; Xie et al., 2008) . It was suggested that LPC-induced intracellular calcium concentration [Ca 2þ ] i in human corporal smooth muscle cells might be involved in hypercholesterolemia-induced erectile function . Coordinately, a tentative LPC receptor, G2A, may also provide pro-atherogenic stimulus to atherosclerotic lesions (Parks et al., 2006) . Therefore, the pro-atherogenic effect of LPC signaling might have negative impact on erectile function. LPA also has atherogenic activity (Siess and Tigyi, 2004) . LPA activity was detected in the seminal plasma . PLA2, an enzyme involved in LPA production, was down-regulated in the corpus cavernosum of hypercholesterolemic rats (Jung et al., 2007) . The significance of LPA signaling in male sexual function is unclear. S1P signaling, on the other hand, may have a positive effect on penile erection, which requires the coordinated arterial endothelium-dependent vasodilation and sinusoidal endothelium-dependent corporal smooth muscle relaxation. S1P 1 , S1P 2 and S1P 3 were detected in the human penile artery and corpus cavernosum. S1P can dramatically boost the relaxation induced by acetylcholine in human corpus cavernosum strips. This effect was mediated through the Ca 2þ -independent Akt-endothelial nitric oxide synthase pathway that led to the production of nitric oxide, the principle peripheral pro-erectile neurotransmitter (di Villa Bianca et al., 2006) .
LP signaling in ovary
The potential role of receptor-mediated LPA signaling in ovary was proposed before the identification of any LP receptor. Early studies demonstrated that LPA induced Ca 2þ -activated Cl 2 current in naked Xenopus laevis oocytes and a receptor-mediated G i protein signaling mechanism was responsible for this effect (Durieux et al., 1992 (Durieux et al., , 1993 . Since then more potential roles of LP signaling in the ovary have been explored.
More recently LPA was detected in follicular fluid and in hens' egg. LPA was present at significant levels in follicular fluid of the human pre-ovulatory follicle . Ovarian stimulation in women may increase LPA levels since serum ATX/lysoPLD activity from patients receiving ovarian stimulation was higher than in women with natural cycles . Concordantly, LPA was induced in incubated human follicular fluid by ATX/lysoPLD . High amounts of acyl LPA (micromolar range) were present in hen egg yolk, predominantly saturated LPA, and hen egg white, predominantly polyunsaturated LPA produced from LPs, suggesting that egg yolk LPA and egg white LPA may play separate physiological roles in the development, differentiation and growth of embryos (Nakane et al., 2001; Morishige et al., 2007) .
The transcripts of LPA 1 , LPA 2 and LPA 4 , but not LPA 3 , are detectable in the mouse ovary (X. Ye and J. Chun, unpublished data) . LPA 1 , LPA 2 and LPA 3 mRNAs are detectable in the granulosa-lutein cells from women undergoing in vitro fertilization (IVF) . LPA 4 has the highest mRNA expression level in the human ovary among all the human tissues that were examined (Noguchi et al., 2003) . The mRNA expression of LPA 5 in ovary has not been examined (Kotarsky et al., 2006; Lee et al., 2006a) .
LPA signaling is involved in oocyte maturation in vitro. LPA, 10 mM, significantly increased the oocyte nuclear and cytoplasmic maturation rates in golden hamster immature oocytes via cumulus cells (Hinokio et al., 2002) . LPA receptor(s) (on cumulus cells), G i and ERK (extracellular signal-regulated kinase)/p38 signaling pathways were involved in the closure or loosening of gap junctions between cumulus cells and the oocyte, leading to an early decrease of oocyte cAMP levels that may promote nuclear maturation of mouse oocytes in vitro (Komatsu et al., 2006) .
The role of LPA in granulosa-lutein cells from women undergoing IVF was recently reported. LPA enhanced the expression of angiogenic cytokines interleukin-6 (IL-6) and IL-8. LPA 1 , G i , MAPK (mitogen-activated protein kinase)/p38, PI3K (phosphoinositol 3-kinase)/Akt and NF-kappaB signaling pathways were involved in the LPA-induced IL-8 expression. LPA 2 , G i , MAPK/p38 and NF-kappaB signaling pathways were involved in the LPA-induced IL-6 expression. It was suggested that LPA in pre-ovulatory follicles may play a role in the angiogenesis of the corpus luteum and the excessive induction of IL-8 and IL-6 by LPA from multiple corpora luteae of stimulated ovaries may be a pathophysiological cause of ovarian hyperstimulation syndrome . Results from LPA 2 transgenic ovaries suggested that the LPA-LPA 2 circuit may regulate ovarian cells both directly and through increases in protein growth factor systems . A recent study demonstrated that deletion of PTEN (phosphatase and tensin homolog deleted on chromosome 10), a major negative regulator of PI3K-Akt signaling pathway, led to activation of entire primordial follicle pool and premature ovarian failure in mice (Reddy et al., 2008) . LP signaling regulates PI3K-Akt signaling pathway (Fig. 1) , whether or not LP signaling is involved in follicle activation remains to be determined.
LPA induced Chinese hamster ovary (CHO) cell growth, migration and lamellipodium formation through G i . LPA 1 may be the key LPA receptor in mediating these effects as LPA 2 and LPA 3 , which also couple to G i , are not expressed in CHO cells. LPA 4 , which may couple to G i , does not seem to be expressed in CHO cells at a significant level and LPA 5 does not couple to G i (Noguchi et al., 2003; Lee et al., 2006a Lee et al., , 2007 Yanagida et al., 2007) . However, when G i function was blocked by pertussis toxin pretreatment, LPA inhibited, rather than induced CHO cell migration in response to insulin-like growth factor I. LPA 1 -G 13 -Rho signaling pathway relayed this inhibitory effect (Yamaji et al., 2004; Sugimoto et al., 2006) .
The effects of LPA signaling in bovine ovarian theca cells and luteal cells are quite complicated. In bovine ovarian theca cells LPA signaling has the following effects: induction of transient ERK phosphorylation through LPA 1 -G 12/13 signaling pathway (Budnik et al., 2003) ; redistribution of protein kinase C d (PKCd) from the cytosol to the perinuclear area; augmentation of luteinizing hormone (LH)-stimulated progesterone accumulation. LPA-induced nuclear localization of PKCd might have a luteotropic function in the bovine ovary (Budnik and Mukhopadhyay, 2002a) . In bovine luteal cells, LPA signaling regulated their morphology but its role in steroid synthesis was opposite to that observed in theca cells. During the development and rescue of the corpus luteum, LH induced major morphoregulatory effects such as formation of stellate processes. LPA inhibited these processes via Rho proteins (Budnik and Mukhopadhyay, 2001) . LPA also dramatically inhibited LH-induced progesterone production on ovarian midcycle luteal cells presumably through LPA 2 and possibly associated with S1P production (Budnik and Brunswig-Spickenheier, 2005) .
The function of LPA signaling in ovulation has not been fully determined. Superovulation data from LPA 3 (2/2) females did not show any suppression of oocyte numbers released compared with the wild-type (WT) controls. This agreed with the result that LPA 3 was not detectable in the mouse ovary. LPA 1 and LPA 2 were expressed in the ovary. Preliminary data from LPA 1 (2/2) LPA 2 (2/2) females indicated that these females had comparable numbers of implantation sites to those of WT females, suggesting that LPA 1 and LPA 2 are not critical for ovulation (X. Ye and J. Chun, unpublished data; Ye et al., 2005) . S1P was identified to be a heat-stable growth factor in the follicular fluid associated with follicular fluid high-density lipoproteins. The S1P concentration was 170 nM (compared with 900 nM in serum) in the human follicular fluid obtained from women undergoing ovarian hyperstimulation. S1P induced endothelial proliferation and angiogenesis through activation of ERK1/2, PKC and Akt signaling pathways, but it is unclear (i) which cell types produce the S1P in the follicular fluid, (ii) how S1P reaches the theca to affect angiogenesis and (iii) which S1P receptors are involved in these processes (von Otte et al., 2006) . Since angiogenesis plays an important role in the development of the ovarian follicle and its subsequent transition into the corpus luteum, the S1P in follicular fluid and its role in angiogenesis underscore S1P signaling as being important in ovarian function.
Indeed, the function of S1P signaling in oocytes, especially the protective role of S1P on oocytes, has been well documented. S1P at 50 mM induced Ca 2þ -activated Cl 2 inward currents in X. laevis oocytes and there was a complete cross-desensitization between LPA and S1P responses (Durieux et al., 1993) . The protective role of S1P on oocytes has at least two aspects. Extracellular S1P not only could protect bovine oocytes from a physiologically relevant heat shock, but also could affect oocyte maturation in the absence of heat shock. The blastocysts that arose from S1P-treated oocytes that survived heat shock had a normal developmental potential. It was suggested that S1P may be used to improve fertility in situations where developmental competence of the oocytes was compromised (Roth and Hansen, 2004) . In addition, S1P-treated oocytes can resist developmental apoptosis, in which the oocyte reserve undergoes normal apoptotic depletion throughout post-natal life. Anti-cancer treatments can lead to premature ovarian failure and infertility. Promisingly, radiation-induced oocyte loss was completely prevented by in vivo therapy with S1P in mice (Morita et al., 2000; Tilly and Kolesnick, 2002) . Pre-administration of S1P into ovarian bursa had protective effects on whole-body irradiation-induced apoptosis of primordial follicles in rats (Kaya et al., 2008) . Local application of S1P in mice also protected ovarian follicles from chemotherapyinduced cell death (Hancke et al., 2007) . These studies provide promises to potentially preserve the fertility of female cancer patients. S1P 3 and GPR3 are expressed in both oocytes and cumulus cells in mice. GPR12 is only detectable in oocytes. Both GPR3 and GPR12 are potential receptors for S1P and SPC. Incubation of mouse oocytes with the GPR3/12 ligands SPC and S1P delayed spontaneous oocyte maturation, an effect that seemed to be opposite of LPA. It was suggested that the cAMP levels required for maintaining meiotic arrest in mouse and rat oocytes were dependent on the expression of GPR3 and/or GPR12 (Hinokio et al., 2002; Hinckley et al., 2005; Komatsu et al., 2006) . The function of S1P signaling in ovary has also been indirectly demonstrated through studies of enzymes involved in S1P metabolism in different species: mutation of SphK2, which catalyzes S1P synthesis, led to diminished ovulation in Drosophila (Herr et al., 2004) ; ovary degeneration was observed in Drosophila with disrupted S1P lyase, in which apoptosis was elevated (Phan et al., 2007) ; when S1P lyase was knocked down in Caenorhabditis elegans, oocyte production and ovulation were impaired (Mendel et al., 2003) ; dihydrosphingosine C4 hydroxylase (DSH) is a key enzyme for sphingolipid production in plants and yeasts and down-regulation of one of the five DSH genes, DSH1, caused sterility in rice plants (Imamura et al., 2007) .
LP signaling in fertilization
Fertilization involves the binding and fusion of sperm and oocyte cells. A main step is acrosome reaction, an exocytotic process that exposes the zona-digesting enzymes around the anterior part of the sperm head and facilitates sperm penetration of the zona pellucida. LPA could activate sperm PKCa, which is implicated in the acrosome reaction, and could promote actin polymerization, a process necessary for spermatozoa incorporation deep into the oocyte cytoplasm. Rho GTPases are involved in the later process but the LPA receptor(s) mediating this process is (are) unknown (Garbi et al., 2000; Delgado-Buenrostro et al., 2005) . However, LPA did not seem to affect bovine sperm motility (Garbi et al., 2000) . No change of sperm motility was observed in mice deficient of three LPA receptors, LPA 1 -3 (Ye et al., 2008) . LPC was able to induce the acrosome reaction in capacitated bovine sperm (Parrish et al., 1988; Therien and Manjunath, 2003) . LPC also accelerated and synchronized the acrosome reaction of hamster spermatozoa, as well as facilitating spermatozoa penetration of the zona pellucida, the fusion process and polyspermy (Riffo and Parraga, 1996) . In addition, the detection of S1P receptors in mouse spermatozoa by RT-PCR led to a speculation that S1P might play a role in the acrosomal reaction (Matsumoto et al., 2005) . Deletion of acid sphingomyelinase, an enzyme regulating sphingolipid signaling, led to impaired sperm motility (Otala et al., 2005) .
LP signaling in oviduct
LPA 1 , LPA 2 , LPA 3 and LPA 4 mRNAs are expressed in the mouse oviduct (X. Ye and J. Chun, unpublished data). LPA at 10 mM could facilitate ovum transport in the mouse oviducts. Although serum LPA levels can reach the concentration effective for ovum transport, the LPA levels in mouse oviduct are unknown. The receptor-mediated G i -Ca 2þ signaling pathway was involved in LPA-induced mouse ovum transport (Kunikata et al., 1999) . Deletion of LPA 1 , LPA 2 or LPA 3 , the three G i -coupled LPA receptors, did not seem to affect the transport of embryos to the mouse uterus (X. Ye and J. Chun, unpublished data; Ye et al., 2005) . This suggests that LPA signaling is not critical for embryo transport in the oviduct under physiological conditions, and/or other G i -coupled LPA receptor(s) are present that compensated for the effect in the LPA receptor knockout mice.
LP signaling in early embryo development
LP signaling is involved in early stage embryo development and postimplantation embryo development processes such as vascular formation, vascular maturation and maintenance, heart development and brain formation (Kupperman et al., 2000; Liu et al., 2000; Allende and Proia, 2002; Contos et al., 2002; Kingsbury et al., 2003; Kono et al., 2004; Mizugishi et al., 2005; Tanaka et al., 2006; van Meeteren et al., 2006; Wendler and Rivkees, 2006) . This section focuses on the LP signaling in early stage embryo development prior to implantation.
An early study revealed that the culture of embryos from the pronuclear stage in the presence of LPA could significantly increase the success rate of the development of 2-cell and 4-cell stage embryos to blastocysts via a G i -protein-linked receptor mechanism (Kobayashi et al., 1994) . A more recent study found mRNA expression of LPA 1 in differentiating mouse blastocysts, expression of LPA 2 in late blastocysts and no expression of LPA 3 . LPA could elevate [Ca 2þ ] i levels, which in turn accelerated murine blastocyst differentiation. LPA could also induce the transient accumulation of heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) on the embryo surface. Interfering with HB-EGF signaling through EGF receptors ErbB1 or ErbB4 could attenuate LPA-stimulated blastocyst differentiation (Liu and Armant, 2004) .
A study of Xenopus also supported the importance of receptormediated LPA signaling in early embryo development (Lloyd et al., 2005) . During early embryo development, the maintenance of overall rigidity and shape of the whole embryo is required for embryogenesis to occur. A cortical actin network of filament bundles assembled in each cell is critical for maintaining embryo shape and rigidity during the egg-to-blastula stage in Xenopus. LPA could increase F-actin in the cortical actin network throughout the animal cap and in the purse-strings, leading to faster healing in the animal cap in early blastula stages in Xenopus. XLPA 1 was most abundant in oocytes (Kimura et al., 2001 ) and expressed at lower levels throughout embryo development; the expression of XLPA 2 began in the mid-blastula stage and continued to at least stage 45, the swimming tadpole. Both XLPA 1 and XLPA 2 were necessary and sufficient for mediating LPA signaling in the correct pattern of cortical actin assembly in Xenopus embryos. Rho and Rac were the responsible downstream signaling molecules.
A recent study in mice demonstrated an anti-apoptotic role of S1P in early embryo development. Acid ceramidase hydrolyzes the pro-apoptotic ceramide into sphingosine, the precursor for the anti-apoptotic S1P (Fig. 1) (Morales and Fernandez-Checa, 2007) . Acid ceramidase knockout embryos underwent apoptotic death and could not survive beyond the 2-cell stage. S1P treatment of early 2-cell embryos from the Asah1 (þ/2) intercrosses not only rescued Asah1 (2/2) embryos, but also enabled their progression from the 2-cell to 4-8-cell stage (Eliyahu et al., 2007) .
LP signaling in embryo spacing and implantation
Embryo spacing is an event relevant to polytocous species in which embryos are implanted nearly equidistant from each other along the uterus. Implantation involves a competent embryo, a receptive uterus, and reciprocal interactions between them to achieve apposition and attachment of the embryo to the uterine luminal epithelium, invasion of the embryo into the stroma and establishment of a placenta (Carson et al., 2000; Paria et al., 2002; Genbacev et al., 2003; Wang and Dey, 2006) . Published reports and recent data have revealed the roles of LP signaling in both embryo spacing and implantation.
LPA signaling influences embryo spacing and uterine receptivity in mice Hama et al., 2007) . Deletion of LPA 3 in mice led to uneven embryo spacing, possibly contributed by defect in uterine contraction, and delayed implantation caused by defect in uterine receptivity. Embryo crowding and delayed implantation were two segregated events based on these observations: (i) restoration of on-time implantation in LPA 3 -null females failed to correct embryo spacing and (ii) when single embryo, which cannot be subject to embryo crowding, was transferred into LPA 3 -null uterus, delayed implantation persisted. Deletion of LPA 3 in mice also led to delayed embryonic development, prolonged pregnancy and 50% embryonic lethality. Ovulation, fertilization, embryo transport, blastocyst development and decidualization were not adversely affected.
Prostaglandins (PGs) were identified to be at least partially responsible for the phenotypes of LPA 3 (2/2) females. Expression of cycloxygenase 2 (COX-2), the rate-limiting enzyme for PG synthesis, as well as PGE 2 and PGI 2 levels were suppressed in the preimplantation embryonic day 3.5 (E3.5) LPA 3 (2/2) uteri. Exogenous PGE 2 and PGI 2 could rescue delayed implantation in the LPA 3 (2/2) females. These results reinforced the importance of PGs in embryo implantation (Kennedy, 1977; Kinoshita et al., 1985; Song et al., 2002) . However, PGE 2 and PGI 2 failed to correct embryo spacing, suggesting that different PGs that control uterine contraction or possible non-PG mechanisms may be responsible for embryo spacing Hama et al., 2007) . Limited studies have identified several other factors that influence embryo spacing: nicotine, phenoxybenzamine and prazosin caused crowding of implantation sites near the utero-tubal junction in rats (Yoshinaga et al., 1979; Legrand et al., 1987) ; estrogen (E 2 ) and histamine increased intrauterine migration of porcine embryos (Pope et al., 1982) ; whereas relaxin reduced intrauterine embryo migration in rat (Pusey et al., 1980) ; deletion of cPLA2a (Song et al., 2002) and inhibition of Wnt/b-catenin signaling (Mohamed et al., 2005) led to aberrant embryo spacing. COX-2/PG pathways were suggested to be involved in the effects of cPLA2a. It is unknown if other factors act through PG pathways and/or if LPA 3 -mediated LPA signaling pathways cross-talk with these factors in regulating embryo spacing.
The embryo implantation defects present in LPA 3 (2/2) females have not been observed in other LP receptor-null females, e.g. LPA 1 (2/2) , LPA 2 (2/2) , S1P 2 (2/2) and S1P 3 (2/2) mice. Among the 10 LP receptors, only LPA 3 was almost exclusively expressed in the luminal endometrial epithelium, while the remaining nine LP receptors were indistinguishably expressed in the luminal endometrial epithelium, stroma and myometrium at E3.5 mouse uterus. In addition, only LPA 3 was up-regulated by progesterone (P4) treatment. The data suggest that the differential expression of LPA 3 in luminal endometrial epithelium and up-regulation of LPA 3 by P4 may distinguish it from other LP receptors for its role in uterine receptivity (X. Ye and J. Chun, unpublished data; Ye et al., 2005; Hama et al., 2006) .
The expression pattern of LPA 3 in pig uterus suggests that LPA 3 may play a role in pigs during early pregnancy. The highest expression level of LPA 3 was detected in the uterus on Day 10-12 of gestation, when an embryo undergoes a dramatic elongation process prior to implantation (Waclawik and Ziecik, 2007) . The presence of embryos also induced pig uterine LPA 3 expression (Kaminska et al., 2007) . This was different from the expression pattern in mice, in which LPA 3 had similar expression patterns in uteri from early pregnant and pseudopregnant mice Hama et al., 2006) . Biomarkers for uterine receptivity have clinical applications, especially in IVF programs. It will be of great interest to examine the expression pattern of LPA 3 in human endometrium to ascertain if it can serve as a potential biomarker for uterine receptivity as can some other potential biomarkers (Campbell and Rockett, 2006) . LPA, acting on decidual cells, can increase embryo outgrowth and induce actin stress fiber formation in human decidual cells. The RhoA signaling pathway mediated the LPA effects in the decidual cells that may regulate embryo development and differentiation after attachment (Shiokawa et al., 2000) .
Preliminary observations indicated comparable numbers of on-time implanted implantation sites and normal embryo spacing in S1P 2 (2/2) S1P 3 (2/2) female mice (X. Ye and J. Chun, unpublished data), suggesting no obvious defects in ovulation, fertilization, embryo transport or uterine receptivity in S1P 2 (2/2) S1P 3 (2/2) females. However, the litter sizes from S1P 2 (2/2) S1P 3 (2/2) females were significantly lower (23 -33% reduction) than that from WT females mated with WT, S1P 2 (þ/2) or S1P 3 (þ/2) control males . These results suggest maternal defects beyond implantation. S1P 1 , S1P 2 and S1P 3 had co-operative functions in mediating S1P signaling in angiogenesis during embryonic development (Liu et al., 2000; Kono et al., 2004) . They were up-regulated during decidualization, suggesting that these three receptors may play co-operative roles in decidual angiogenesis as well (SkaznikWikiel et al., 2006) . Enzymes involved in sphingolipid metabolism were also up-regulated in the uterus during decidualization (KanekoTarui et al., 2007) . The importance of this regulation was confirmed in SphK1 (2/2)
SphK2
(þ/2) females that showed decidualization defects. There is a link between S1P and PG signaling in early pregnancy, but PG signaling did not seem to be critical for the decidualization defects in the SphK1 (2/2) SphK2 (þ/2) females (Mizugishi et al., 2007) .
LP signaling in pregnancy and parturition
The involvement of LP signaling in pregnancy beyond implantation could be multi-faceted. First, LPA signaling has been suggested in the maintenance of human pregnancy as serum ATX/lysoPLD activity, a key enzyme for LPA production, and LPA levels were shown to increase during pregnancy . High lysophospholipase activity was present in the human placental tissues with the highest in the amnion (Jarvis et al., 1984) . Although amnion has been heavily implicated in the initiation of labor presumably through the release of arachidonic acid, the high lysophospholipase activity in amnion suggests that its products, including LPs, might also involve in the regulation of labor.
Second, LP signaling has potential functions in placental and vascular tone during pregnancy. High levels of LPA 2 and LPA 3 expression in the placentas of patients with hypertensive disorder suggest that LPA signaling might be involved in this complication . Hypertensive disorder can worsen with the progress of pregnancy. LPA levels increase during pregnancy. It is unknown whether even higher levels of LPA are present in the pregnant patients complicated with hypertensive disorder. LPA 1 , LPA 3 , LPA 4 and LPA 5 mRNAs were also detectable in mouse placenta (X. Ye and J. Chun, unpublished data; Noguchi et al., 2003; Kotarsky et al., 2006) . The functions of LPA signaling in placenta await further exploration.
Several reports show the roles of S1P signaling in placental trophoblast differentiation and vascular tone. S1P inhibited the differentiation of primary human cytotrophoblasts into syncytiotrophoblasts. This inhibition of differentiation was mediated through S1P 1 -3 , G i , adenylate cyclase and intracellular cAMP. The study suggested that S1P signaling may play a role in pregnancy disorders, such as pre-eclampsia, that are related to improper differentiation of placental trophoblasts (Johnstone et al., 2005) . S1P induced vasoconstriction in human placental arteries, a process mediated by increased Ca 2þ -sensitization via Rho-associated kinases and modulated by nitric oxide (Hemmings et al., 2006) . S1P also induced the isometric tension of myometrial arteries isolated from normal pregnant women at term. S1P 1 , S1P 2 and S1P 3 were detected in these arteries. These results suggest that S1P may help regulate vascular tone during pregnancy (Hudson et al., 2007) .
Third, the following studies suggest that LP signaling could potentially regulate uterine contractility as well as load-bearing during pregnancy and labor. An early study indicated that LPA had similar effects as PGF 2a on rat smooth muscle contraction and intrauterine pressure (Tokumura et al., 1980) . Although the effect of LPA signaling in parturition per se has not been established in vivo, deletion of FP, the GPCR for PGF 2a , led to parturition failure (Sugimoto et al., 1997) . LPA stimulated myosin light chain phosphorylation through RhoA signaling in pregnant myometrial tissue (Moore et al., 2000) . LPA also induced stress fiber formation that may be involved in the maintenance of uterine contractions. The G 12/13 -Rho kinase signaling pathway was suggested to mediate this effect (Gogarten et al., 2001) . In addition, the G i/o signaling pathway involving the regulation of [Ca 2þ ] i was responsible for LPA-induced cell proliferation of human myometrial smooth muscle cells (Nilsson et al., 1998) . A follow-up study identified the critical role of Ca 2þ /calmodulindependent protein kinase in this effect as well as the detection of LPA 1 , LPA 2 and LPA 3 in the human myometrial smooth muscle cells (Nilsson and Svensson, 2003) .
LPC may play a role in infection-related preterm labor. Significant higher level of LPC was detected in human uterine endometrial cells upon exposure to extract from common anaerobes in intrauterine infection, accompanied with an elevation of arachidonic acid, a key precursor for PG synthesis in regulating labor. PLA2 activity was involved in the reported lipid metabolism (Mikamo et al., 1998a, b) . Since PLA2 and LPC are important components in the LPA metabolism pathway (Fig. 1) (Aoki, 2004) , it is reasonable to expect that LPA might also be involved in the infection-related preterm labor. S1P can induce a contractile effect in rat myometrium presumably through S1P 2 (Leiber et al., 2007) . S1P may play a role in labor. S1P was identified as one of the components in the amniotic fluid that can modulate the synthesis of PGs, key regulators of labor (Sugimoto et al., 1997) , in human amnion-derived cells . In addition, SphK1, a key enzyme for S1P production, was detected in rat glandular epithelium, vasculature and the myometrium, and was up-regulated by P4. A recent study also suggested that SphK1 involved growth and differentiation of uterine tissues during pregnancy (Jeng et al., 2007) .
LP signaling in cancer
A number of articles have reviewed the roles of LP signaling in various cancers (Mills and Moolenaar, 2003; Xu et al., 2003; Brindley, 2004; Milstien and Spiegel, 2006; Sabbadini, 2006; Bandhuvula and Saba, 2007; Morales and Fernandez-Checa, 2007; Murph and Mills, 2007; Oskouian and Saba, 2007; Tokumura et al., 2007; Van Brocklyn, 2007; van Meeteren and Moolenaar, 2007) . LPA levels increased in the plasma and ascites of patients with ovarian cancer, cervical cancer or endometrial cancer (Shen et al., 1998; Mills et al., 2002; Tokumura et al., 2007) . LPs were suggested as potential biomarkers for these cancers (Umezu-Goto et al., 2004) . This section only covers the potential roles of LP signaling in cancers in reproductive organs, such as ovary, cervix, mammary gland and prostate, as well as in related cell lines.
Ovarian cancer is the most extensively studied cancer with respect to LP signaling in carcinogenesis. Early studies demonstrated LPA, whose levels elevated in the plasma and ascites of ovarian cancer patients, promoted ovarian cancer cell proliferation. LPA, S1P and LPC were suggested as potential biomarkers for ovarian cancers and LPA-like lipids were proposed as being responsible for intraperitoneal malignancies (Xu et al., 1995a (Xu et al., , b, 1998 Westermann et al., 1998; Sutphen et al., 2004) . However, another study indicated that serum LPA could not differentiate benign from malignant ovarian tumors (Pozlep et al., 2007) . LPA acyltransferase beta, which converts LPA to PA, was suggested as a specific prognostic marker (Niesporek et al., 2005; Springett et al., 2005) . The increased production of LPA might be related to the down-regulation of LPP1, which degrades LPA, in ovarian cancer cells (Tanyi et al., 2003) .
LPA signaling may exert its role in ovarian cancers through regulating other factors: glycodelin, an angiogenic protein with a potential immunosuppressive role in carcinogenesis (Ramachandran et al., 2002) ; TRIP6 (thyroid receptor interacting protein 6), a focal adhesion molecule involved in cell migration ; telomerase, a ribonucleprotein expressed in 95% of ovarian cancers and involved in tumor progress (Bermudez et al., 2007) ; granulin-epithelin precursor, a growth and survival factor for ovarian cancer (Kamrava et al., 2005) ; internalization of Fas from the cell membrane to the cytosol, a process that would protect ovarian cancer cells from FasL-bearing immune cells (Meng et al., 2005) ; IL-6 and IL-8, angiogenic cytokines (Chou et al., 2005) ; COX-2, which potentiates aggressive cellular behavior (Symowicz et al., 2005) ; growth-regulated oncogene alpha (GROalpha), a chemokine with increased levels detected in the plasma and ascites of ovarian cancer patients (Lee et al., 2006b ) and urokinase plasminogen activator (uPA), a critical component present at high concentration in ovarian ascites and ovarian cancers which bears an inverse correlation with cancer prognosis (Pustilnik et al., 1999; Estrella et al., 2007; Gil et al., 2008) .
LPA receptors seem to play different roles in the ovarian cancers. LPA 2 and LPA 3 but not LPA 1 were up-regulated in ovarian cancer tissues (Nakamoto et al., 2005; Wang et al., 2007a) . LPA 2 was a key receptor in mediating LPA-induced production of GROalpha (Lee et al., 2006b) . LPA-induced uPA secretion in ovarian cancer cells was dominantly mediated through LPA 2 with contribution from LPA 3 (Pustilnik et al., 1999; Estrella et al., 2007) . LPA 3 was a key receptor for mediating the chemotactic activity of LPA (Sengupta et al., 2003) . However, LPA 1 seemed to be the key receptor in mediating ascitic LPA effects on other cells (Yamada et al., 2004; Sako et al., 2006) . Several LPA downstream signaling pathways have been identified in ovarian cancer cells. The up-regulation of uPA by LPA was mainly mediated through the G i -Ras-PKCa-CARMA3-NF-kappaB signaling pathway in ovarian cancer cells. CARMA3 (CARD and MAGUK domain-containing protein 3) is a scaffolding protein required for GPCR-induced NF-kappaB activation (Li et al., 2005; Grabiner et al., 2007; Mahanivong et al., 2008) . Both G i -Ras-MEKK1 (MAPK kinase kinase 1) and G 12/13 -RhoA-ROCK (Rho-associated kinase) signaling pathways contributed to LPA-stimulated ovarian cancer cell migration by facilitating focal adhesion kinase redistribution and autophosphorylation, respectively (Sawada et al., 2002; Bian et al., 2004 Bian et al., , 2006 . LPA signaling in ovarian cancer cells could be attenuated by RGS, a regulator of G protein signaling proteins that deactivates G proteins (Hurst et al., 2008) . LPA-induced IL-6 expression was via a G i /PI3K-Akt/NF-kappaB pathway (Chou et al., 2005) , while transcription factors NF-kappaB and AP-1, which were induced by LPA, might synergistically stimulate IL-8 expression (Fang et al., 2004) . S1P was also identified in the ascites of ovarian cancer patients and as a mitogenic and cell survival factor for ovarian cancer cells (Hong et al., 1999) . At low concentrations S1P had an invasive effect similar to LPA, but S1P inhibited the invasiveness at high concentrations. The dual effects on ovarian cancer invasion were probably through the regulation of LP receptors (Smicun et al., 2006 (Smicun et al., , 2007 . S1P induced [Ca 2þ ] i and chemotactic migration of ovarian cancer cells. S1P 1/2/3 -G i -ERK/p38 MAPK/Akt mediated these effects . S1P and SPC had an effect similar to LPA on induction of IL-8 expression (Schwartz et al., 2001) .
The cervical cancer cell line HeLa has been used to study the roles of LPs in cervical cancer. LPA induced HeLa cell migration and survival. S1P 1 , S1P 2 and S1P 3 were detectable in HeLa cells, but only over-expressed S1P 2 and S1P 3 seemed to mediate S1P-induced [Ca 2þ ] i and cell survival (Rapizzi et al., 2007) , whereas S1P 1 seemed to mediate HeLa cell proliferation (Xu et al., 2006) . A class II PI3K-activated signaling pathway was identified as mediating cell migration (Maffucci et al., 2005) , while the G i/o -PI3K-Akt signaling cascade was responsible for survival (Fang et al., 2000) . Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is able to induce apoptosis in many cancer cells. Both S1P and LPA inhibited TRAIL-induced apoptosis in HeLa cells. This anti-apoptotic effect of LPs involved the activation of the PI3K-Akt signaling pathway (Kang et al., 2004) .
LP signaling may also play a role in breast cancer progression. Human mammary gland expressed LPA 1 , LPA 2 and a lower level of LPA 3 . The up-regulation of LPA 2 , but not that of LPA 1 and LPA 3 , in the mammary gland carcinoma tissue and post-menopausal women suggest that LPA 2 may be related to breast cancer, especially postmenopausal breast cancer (Kitayama et al., 2004) . Studies from breast cancer cell lines indicated that both LPA 1 and LPA 2 could mediate LPA-induced chemotaxis in breast carcinoma cells, but LPA 1 was more efficacious than LPA 2 (Chen et al., 2007) . LPA 1 was also considered to be the culprit for LPA-promoted breast cancer cell migration (Stadler et al., 2006) and metastasis in bone (Boucharaba et al., 2004 (Boucharaba et al., , 2006 . LP signaling might be involved in breast cancer cell proliferation (Imagawa et al., 1995; Xu et al., 1995a) . LPA induced stress fiber and focal adhesion formation in breast cancer cells (Dorfleutner et al., 2007) . EGF receptor, whose overexpression is a prognostic indicator of a poor outcome in multiple tumor types, was identified to be in the signaling network for LPA-induced breast cancer progression (Boerner et al., 2005) . The effects of LPA on breast cancer cells could be potentiated by insulin through the induction of geranylgeranylated RhoA, and consequently the augmentation of LPA-induced cyclin E expression and degradation of p27 Kip1 (cyclindependent kinase inhibitor) and cell cycle progression (Chappell et al., 2000 (Chappell et al., , 2001 . LPA and S1P could promote the migration of metastatic human breast cancer cells (Sliva et al., 2000) . S1P could induce [Ca 2þ ] i and chemokinetic migration in human breast cancer cells, a process that might be mediated through S1P 2 and S1P 3 , but not S1P 1 (Dolezalova et al., 2003) .
LPA 1 , LPA 2 and LPA 3 were detected in the prostate. They had significantly higher expression levels in malignant compared with the benign prostate tissues (Im et al., 2000b; Guo et al., 2006) . LPA signaling plays multiple roles in prostate cancer: facilitating early prostate cancer development by inhibiting autophagy (Chang et al., 2007) ; inducing prostate cancer cell proliferation, survival, morphological changes, migration and invasion. LPA 1 seemed to be the key receptor in mediating LPA-induced prostate cancer cell proliferation and migration (Daaka, 2002; Guo et al., 2006; Hao et al., 2007) . Tyrosine kinase EGF and matrix metalloproteinases were involved in the LPA-induced ERK mitogenic signaling pathway (Kue et al., 2002) . The LPA receptor-Akt-NF-kappaB signaling axis may mediate LPA-induced prostate cell survival (Raj et al., 2004) . LPA may also play its roles via the involvement of other factors: phosphorylation of proline-rich tyrosine kinase 2, a potential marker in prostate epithelium for the malignancy of prostate cancer (Picascia et al., 2002) ; IL-6, which appeared to mediate LPA-induced prostate cancer cell growth and the cross-talk between stromal and epithelial prostate cells (Sivashanmugam et al., 2004) ; CYR61, an extracellular matrix signaling protein implicated as a secreted autocrine and/or paracrine mediator for LPA in prostate stromal and epithelial hyperplasia (Sakamoto et al., 2004) . LPA stimulated prostate cancer cell invasion through alterations of RhoA and NF-kappaB activity (Hwang et al., 2006) . RhoA also played a role in LPA-induced morphological changes of prostate cancer cells . LPA-induced Rho activation was dependent on PDZrhoGEF, a rho guanine nucleotide exchange factors . S1P signaling, on the other hand, mainly serves as an anti-apoptotic factor in prostate cancer. Sphk1 balances the ratio of ceramide/S1P. Overexpression of SphK1, which increases the production of S1P and decreases ceramide/S1P ratio, impaired the efficacy of chemotherapy; whereas inhibition of SphK1 was related to a smaller tumor volume as well as reduced occurrence and number of metastases (Pchejetski et al., 2005) . Up-regulation of S1P 1 , S1P 3 and SphK1 also accounted for prostate cancer cell escape from anti-cancer drug-induced apoptosis (Akao et al., 2006) .
Closing remarks
The abundant presence of signaling LPs in the serum and other biological fluids provides them the opportunity to reach almost every tissue. The potential functions of LP signaling in each tissue are likely determined by many local factors, such as LP metabolism, expression and regulation of LP receptors, and other factors in the LP signaling pathways. The progress on understanding LP signaling in reproduction has been exciting, yet more comprehensive studies on the factors influencing tissue-specific functions as well as receptorspecific functions are needed. The mechanisms of LP signaling in the physiological and pathological reproductive tissues await further exploration to ensure the clarification of LP signaling as a therapeutic target and for the development of modulating agents (Mills and Moolenaar, 2003; Chun and Rosen, 2006; Milstien and Spiegel, 2006; .
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